Hua Liu
Directeur/Bestuurslid bij Beijing Xiangxin Biotechnology Co., Ltd.
Actieve functies van Hua Liu
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
Beijing Xiangxin Biotechnology Co., Ltd.
 Beijing Xiangxin Biotechnology Co., Ltd. BiotechnologyHealth Technology Beijing Xiangxin Biotechnology Co., Ltd. was founded in 2018 and is based in the economic-technological development area. The Chinese company has established two R & D centers covering a total area of 5,000 square meters. The company provides comprehensive solutions for cancer precision medicine using genomics technologies, with a focus on next-generation sequencing (NGS) in solid tumors and hematological malignancies. Acornmed has launched over 30 clinical testing products covering early detection and screening of multiple cancers, hereditary cancer identification, companion diagnostics for targeted therapy and immunotherapy, prognostic stratification, longitudinal monitoring of tumors, etc. The company has served more than 500 hospitals and have been endorsed by many clinical oncologists and laboratory professionals. | Directeur/Bestuurslid | 07-03-2019 | - |
Loopbaan van Hua Liu
Eerdere bekende functies van Hua Liu
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| TAI UNITED HOLDINGS LIMITED | Directeur/Bestuurslid | 08-01-2015 | 27-10-2017 |
| Algemeen Directeur | 19-01-2016 | 08-06-2016 | |
| Donghai Securities Co., Ltd. (Broker) | Corporate Officer/Principal | 01-09-2014 | 01-11-2015 |
GTJA Innovation Investment Co. Ltd.
 GTJA Innovation Investment Co. Ltd. Investment ManagersFinance GTJA Innovation Investment Co. Ltd. is a private equity and venture capital firm founded in 2009, headquartered in Shanghai. | Directeur/Bestuurslid | - | - |
Opleiding van Hua Liu
| Imperial College London | Graduate Degree |
| University of Cambridge | Doctorate Degree |
| Tsinghua University | Undergraduate Degree |
Statistieken
Internationaal
| China | 5 |
| Verenigd Koninkrijk | 3 |
| Hongkong | 2 |
Operationeel
| Director/Board Member | 3 |
| Chief Executive Officer | 1 |
| Undergraduate Degree | 1 |
Sectoraal
| Finance | 4 |
| Consumer Services | 4 |
| Health Technology | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| TAI UNITED HOLDINGS LIMITED | Finance |
| Bedrijven in privébezit | 3 |
|---|---|
| Donghai Securities Co., Ltd. (Broker) | Finance |
GTJA Innovation Investment Co. Ltd.
GTJA Innovation Investment Co. Ltd. Investment ManagersFinance GTJA Innovation Investment Co. Ltd. is a private equity and venture capital firm founded in 2009, headquartered in Shanghai. | Finance |
Beijing Xiangxin Biotechnology Co., Ltd.
Beijing Xiangxin Biotechnology Co., Ltd. BiotechnologyHealth Technology Beijing Xiangxin Biotechnology Co., Ltd. was founded in 2018 and is based in the economic-technological development area. The Chinese company has established two R & D centers covering a total area of 5,000 square meters. The company provides comprehensive solutions for cancer precision medicine using genomics technologies, with a focus on next-generation sequencing (NGS) in solid tumors and hematological malignancies. Acornmed has launched over 30 clinical testing products covering early detection and screening of multiple cancers, hereditary cancer identification, companion diagnostics for targeted therapy and immunotherapy, prognostic stratification, longitudinal monitoring of tumors, etc. The company has served more than 500 hospitals and have been endorsed by many clinical oncologists and laboratory professionals. | Health Technology |
